Table 1. Age-Specific Seroprevalence of MCPyV.
Age, y | Total Number of Samples | Seroprevalence in Males | Seroprevalence in Females | Total Seroprevalence |
---|---|---|---|---|
≤ 10 | 53 | |||
Positive | 6 | 7 | 13 | |
Negative | 25 | 28 | 53 | |
Positive percentage | 24 | 25 | 25 | |
10 – 19 | 45 | |||
Positive | 14 | 11 | 25 | |
Negative | 23 | 22 | 45 | |
Positive percentage | 61% | 50 | 56 | |
20 – 29 | 43 | |||
Positive | 10 | 16 | 26 | |
Negative | 20 | 23 | 43 | |
Positive percentage | 50 | 70 | 60 | |
30 – 39 | 68 | |||
Positive | 22 | 20 | 42 | |
Negative | 31 | 37 | 68 | |
Positive percentage | 71 | 54 | 62 | |
40 – 49 | 86 | |||
Positive | 25 | 30 | 55 | |
Negative | 40 | 46 | 86 | |
Positive percentage | 63 | 65 | 64 | |
50 – 59 | 70 | |||
Positive | 22 | 23 | 45 | |
Negative | 36 | 34 | 70 | |
Positive percentage | 61 | 68 | 64 | |
60 – 69 | 40 | |||
Positive | 13 | 14 | 27 | |
Negative | 19 | 21 | 40 | |
Positive percentage | 68 | 67 | 68 | |
≥ 70 | 35 | |||
Positive | 11 | 11 | 22 | |
Negative | 17 | 18 | 35 | |
Positive percentage | 65 | 67 | 63 |